{"id":"https://openalex.org/W2097559596","doi":"https://doi.org/10.1111/j.1365-2265.1988.tb01225.x","title":"LONG\u2010TERM TREATMENT WITH A NEW NON\u2010ERGOT LONG\u2010ACTING DOPAMINE AGONIST, CV 205\u2010502, IN WOMEN WITH HYPERPROLACTINAEMIA","display_name":"LONG\u2010TERM TREATMENT WITH A NEW NON\u2010ERGOT LONG\u2010ACTING DOPAMINE AGONIST, CV 205\u2010502, IN WOMEN WITH HYPERPROLACTINAEMIA","publication_year":1988,"publication_date":"1988-09-01","ids":{"openalex":"https://openalex.org/W2097559596","doi":"https://doi.org/10.1111/j.1365-2265.1988.tb01225.x","mag":"2097559596","pmid":"https://pubmed.ncbi.nlm.nih.gov/2908030"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2265.1988.tb01225.x","doi":"https://doi.org/10.1111/j.1365-2265.1988.tb01225.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.1988.tb01225.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103470534","display_name":"Carsten Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"CARSTEN RASMUSSEN","raw_affiliation_strings":["Department of Obstetrics and Gynaecology, Uppsala University, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Obstetrics and Gynaecology, Uppsala University, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110332397","display_name":"Torbj\u00f6rn Bergh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]},{"id":"https://openalex.org/I4388891806","display_name":"Sandoz Group AG (Switzerland)","ror":"https://ror.org/02rse7p59","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4388891806"]}],"countries":["CH","SE"],"is_corresponding":false,"raw_author_name":"TORBJ\u00d6RN BERGH","raw_affiliation_strings":["Departments of Obstetrics and Gynaecology and Clinical Chemistry, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden and Sandoz Ltd, Basle, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Obstetrics and Gynaecology and Clinical Chemistry, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden and Sandoz Ltd, Basle, Switzerland","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I1342360035","https://openalex.org/I4388891806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066313081","display_name":"LEIF E. WIDE","orcid":"https://orcid.org/0000-0002-4139-382X","observed_orcids":["https://orcid.org/0000-0002-4139-382X"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]},{"id":"https://openalex.org/I4388891806","display_name":"Sandoz Group AG (Switzerland)","ror":"https://ror.org/02rse7p59","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4388891806"]}],"countries":["CH","SE"],"is_corresponding":false,"raw_author_name":"LEIF WIDE","raw_affiliation_strings":["Departments of Obstetrics and Gynaecology and Clinical Chemistry, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden and Sandoz Ltd, Basle, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Obstetrics and Gynaecology and Clinical Chemistry, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden and Sandoz Ltd, Basle, Switzerland","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I1342360035","https://openalex.org/I4388891806"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040869753","display_name":"Judith Brownell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]},{"id":"https://openalex.org/I1342360035","display_name":"Uppsala University Hospital","ror":"https://ror.org/01apvbh93","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1342360035"]},{"id":"https://openalex.org/I4388891806","display_name":"Sandoz Group AG (Switzerland)","ror":"https://ror.org/02rse7p59","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4388891806"]}],"countries":["CH","SE"],"is_corresponding":false,"raw_author_name":"JUDITH BROWNELL","raw_affiliation_strings":["Departments of Obstetrics and Gynaecology and Clinical Chemistry, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden and Sandoz Ltd, Basle, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Obstetrics and Gynaecology and Clinical Chemistry, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden and Sandoz Ltd, Basle, Switzerland","institution_ids":["https://openalex.org/I123387679","https://openalex.org/I1342360035","https://openalex.org/I4388891806"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5103470534"],"corresponding_institution_ids":["https://openalex.org/I123387679"],"apc_list":{"value":4250,"currency":"USD","value_usd":4250},"apc_paid":null,"fwci":4.254,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.94584663,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"29","issue":"3","first_page":"271","last_page":"279"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10960","display_name":"Hypothalamic control of reproductive hormones","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperprolactinemia","display_name":"hyperprolactinemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/bromocriptine","display_name":"bromocriptine","score":0.8230000138282776},{"id":"https://openalex.org/keywords/galactorrhea","display_name":"galactorrhea","score":0.9160000085830688},{"id":"https://openalex.org/keywords/prolactin-secretion","display_name":"prolactin secretion","score":0.9150000214576721},{"id":"https://openalex.org/keywords/menstrual-regularity","display_name":"menstrual cycle regularity","score":0.8320000171661377},{"id":"https://openalex.org/keywords/bromocriptine-resistance","display_name":"bromocriptine resistance","score":0.8790000081062317},{"id":"https://openalex.org/keywords/women","display_name":"women","score":0.3490000069141388},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C2781401123","wikidata":"https://www.wikidata.org/wiki/Q1433936","display_name":"Hyperprolactinaemia","level":4,"score":0.9031368494033813},{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.8935298919677734},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7386329770088196},{"id":"https://openalex.org/C2778258207","wikidata":"https://www.wikidata.org/wiki/Q600203","display_name":"Dopamine agonist","level":4,"score":0.6867619752883911},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6610806584358215},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.5973113179206848},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5779350996017456},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.48509538173675537},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42441526055336},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.20168864727020264},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18758702278137207}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000634","descriptor_name":"Aminoquinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005687","descriptor_name":"Galactorrhea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015259","descriptor_name":"Dopamine Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2265.1988.tb01225.x","doi":"https://doi.org/10.1111/j.1365-2265.1988.tb01225.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2265.1988.tb01225.x","pdf_url":null,"source":{"id":"https://openalex.org/S182143151","display_name":"Clinical Endocrinology","issn_l":"0300-0664","issn":["0300-0664","1365-2265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Endocrinology","raw_type":"journal-article"},{"id":"pmid:2908030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2908030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical endocrinology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W57856350","https://openalex.org/W1981882991","https://openalex.org/W1991092276","https://openalex.org/W2010563165","https://openalex.org/W2014029636","https://openalex.org/W2037774020","https://openalex.org/W2101548190","https://openalex.org/W2108160925","https://openalex.org/W2119216341","https://openalex.org/W2985627329","https://openalex.org/W4211084189"],"related_works":["https://openalex.org/W2145502085","https://openalex.org/W2027216795","https://openalex.org/W2440576098","https://openalex.org/W2402840599","https://openalex.org/W2072630809","https://openalex.org/W2025792694","https://openalex.org/W2055165503","https://openalex.org/W2016054538","https://openalex.org/W2670307533","https://openalex.org/W2091426277"],"abstract_inverted_index":{"Twenty-four":[0],"hyperprolactinaemic":[1,54],"women":[2,30,45],"were":[3,130],"treated":[4],"for":[5],"6":[6,110],"months":[7],"with":[8,147],"the":[9,28,40,61,106,143],"new,":[10],"non-ergot,":[11],"long-acting":[12],"dopamine":[13],"agonist,":[14],"CV":[15,77,92,134],"205-502.":[16,78],"The":[17],"treatment":[18,112],"resulted":[19],"in":[20,25,103,118,142],"normalization":[21],"of":[22,27,34,39,43,50,60,69,105,122,145],"PRL":[23,127],"secretion":[24],"17":[26],"24":[29,107],"at":[31,101],"once-daily":[32],"doses":[33],"0.05":[35],"to":[36,91,96,137],"0.15":[37],"mg":[38],"drug.":[41],"Sixteen":[42],"these":[44],"as":[46,48],"well":[47],"4":[49],"those":[51],"who":[52],"remained":[53,89],"had":[55,63,73,124],"regular":[56],"menstrual":[57],"bleeding.":[58],"Five":[59],"patients":[62,146],"previously":[64],"discontinued":[65],"bromocriptine":[66],"therapy":[67],"because":[68],"adverse":[70],"effects":[71],"but":[72],"no":[74],"problems":[75],"tolerating":[76],"Of":[79],"three":[80],"bromocriptine-resistant":[81],"women,":[82],"two":[83],"responded":[84],"partially":[85],"while":[86],"one":[87],"also":[88],"unresponsive":[90],"205-502":[93,135],"treatment.":[94],"Mild":[95],"moderate":[97],"galactorrhoea":[98,114],"was":[99,115],"recorded":[100],"baseline":[102],"19":[104],"women.":[108],"After":[109],"months'":[111],"mild":[113,131],"still":[116],"present":[117],"six":[119],"patients,":[120],"four":[121],"whom":[123],"attained":[125],"normal":[126],"levels.":[128],"Side-effects":[129],"and":[132],"transient.":[133],"seems":[136],"be":[138],"a":[139],"valuable":[140],"compound":[141],"management":[144],"hyperprolactinaemia.":[148]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}